![Emerita Esther Shohami](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Emerita Esther Shohami
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
BrainQ Technologies Ltd.
![]() BrainQ Technologies Ltd. Packaged SoftwareTechnology Services BrainQ Technologies Ltd. develops a detection and non-invasive treatment technology to help patients with paralysis move their limbs. The company was founded by Segal Yaron, Drechsler Yotam, and Shohami Emerita Esther on August 14, 2011 and is headquartered in Jerusalem, Israel.
6
| Holding Company | Packaged Software | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Emerita Esther Shohami via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
KERYX BIOPHARMACEUTICALS | Pharmaceuticals: Major | Chief Executive Officer | |
XTL BIOPHARMACEUTICALS LTD. | Medical Specialties | Founder | |
State University of New York at Albany | College/University | Undergraduate Degree | |
Moscow State University Lomonosov | College/University | Undergraduate Degree | |
BIOLINERX LTD. | Pharmaceuticals: Major | Founder | |
State University of New York at Downstate Medical Center | College/University | Doctorate Degree | |
University of Potsdam | College/University | Doctorate Degree | |
SCINAI IMMUNOTHERAPEUTICS LTD. | Pharmaceuticals: Other | Director/Board Member | |
Dynamix Pharmaceuticals Ltd.
![]() Dynamix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Dynamix Pharmaceuticals Ltd. discovers and develops small-molecule drugs for treating cancer and autoimmune disorders. It focuses its discovery on cancer metabolism modulators and type II selective kinase inhibitors. The firm offers DNX-03000 that targets Pyruvate Kinase M2 (PKM2), an enzyme that is a key mediator of cancer metabolism; and DNX-06000 that targets an undisclosed target. The company was founded by Oren M. Becker in 2009 and is headquartered in Rehovot, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Paramount Capital Investments LLC | Corporate Officer/Principal | ||
Pharmapark LLC
![]() Pharmapark LLC Pharmaceuticals: MajorHealth Technology Part of Bioprocess Holding, Pharmapark LLC is a privately-owned Russian biopharmaceutical company that specializes in the development, manufacture, and commercialization of biosimilar products. The company is based in Moscow, Russian Federation. The company has a successful track record of performing complete biotechnological drug development through commercial production and has marketed five biosimilar products. Pharmapark also has an in-house pipeline of novel formulations and biosimilars focused on value-adding treatments. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
OurCrowd Management Ltd.
![]() OurCrowd Management Ltd. Investment ManagersFinance OurCrowd Management Ltd (OurCrowd) is a venture capital firm founded in 2013 by Jonathan Medved and Steven Blumgart. The firm is headquartered in Jerusalem, Israel. | Investment Managers | Private Equity Investor | |
Promogen-MAT LLC
![]() Promogen-MAT LLC Medical/Nursing ServicesHealth Services Promogen-MAT LLC operates as a drug development company. The company was founded in 2010 and is headquartered in Moscow, Russian Federation. | Medical/Nursing Services | Chief Operating Officer | |
PURPLE BIOTECH LTD | Pharmaceuticals: Major | Chief Executive Officer | |
HIL Applied Medical Ltd.
![]() HIL Applied Medical Ltd. Medical SpecialtiesHealth Technology HIL Applied Medical Ltd. develops cancer Proton Therapy systems. It applies a patented approach, combining nanotechnology, and high-intensity lasers for its solutions. The company was founded by Shmuel Eisenmann and Arie Zigler in 2010 and is headquartered in Jerusalem, Israel. | Medical Specialties | Director/Board Member | |
Nanolabz, Inc.
![]() Nanolabz, Inc. Medical SpecialtiesHealth Technology Nanolabz, Inc. develops a technology system for cancer proton radiation therapy. It develops and sells laser physics targets for the short-pulse laser research and development sector. The company was founded by Steven Malekos, Jesse Adams, and Grant Korgan and is headquartered in Sparks, NV. | Medical Specialties | Director/Board Member | |
Endogenex, Inc.
![]() Endogenex, Inc. Medical/Nursing ServicesHealth Services DyaMX, Inc. provides health care services. The company is headquartered in Plymouth, MN. | Medical/Nursing Services | Chief Executive Officer | |
Melcap Systems Ltd. | Director/Board Member | ||
Broadq Technologies Ltd. | Director/Board Member | ||
Vigorous Solutions Ltd. | Director/Board Member | ||
Ocular Discovery Ltd. | Director/Board Member | ||
SCOPUS BIOPHARMA INC. | Pharmaceuticals: Other | Chief Executive Officer | |
Dreamed Diabetes Ltd.
![]() Dreamed Diabetes Ltd. Packaged SoftwareTechnology Services DreaMed Diabetes Ltd. is a medical technology company based in Petach Tikva, Israel. DreaMed Diabetes is currently commercializing its endo.digital AI-based clinical decision support system for diabetes management. The endo.digital platform has FDA clearance for patients with type 1 diabetes using continuous glucose monitors or self-monitoring blood glucose monitor devices and insulin pumps. The technology also received expanded FDA clearance to include patients with type 1 or type 2 diabetes on multiple daily injections. The Israeli company's first product, an artificial pancreas technology, was licensed to Medtronic and incorporated into its 780g insulin pump technology. The company provides personalized diabetes treatment optimization solutions and was founded in 2014 by Revital Nimri, Tadej Battelino, Eran Atlas, Thomas Danne, and Ido Muller. Eran Atlas has been the CEO since 2014. | Packaged Software | Director/Board Member | |
Ourcrowd Medtech Fund
![]() Ourcrowd Medtech Fund Investment ManagersFinance OurCrowd Medtech Fund invests in companies located in Israel. The fund targets operating in the fields of medical devices, therapeutics, medical robotics. It provides financing for early stage capital requirements. | Investment Managers | Corporate Officer/Principal | |
OncoHost Ltd.
![]() OncoHost Ltd. Miscellaneous Commercial ServicesCommercial Services OncoHost Ltd. is an Israeli technology company that combines life-science research and advanced machine learning technology to develop personalized strategies to maximize the success of cancer therapy. The company utilizes proprietary proteomic analysis to understand a patient's unique response to therapy and overcome resistance to therapy. OncoHost's host response profiling platform (Prophet®) analyzes proteomic changes in blood samples to monitor the dynamics of biological processes induced by the patient in response to a given cancer therapy. OncoHost was founded in 2017, and the CEO is Ofer Sharon. | Miscellaneous Commercial Services | Chairman | |
BUTTERFLY NETWORK, INC. | Medical Specialties | Corporate Officer/Principal | |
Clil Medical Ltd. | Chief Executive Officer |
Statistieken
Internationaal
Israël | 18 |
Verenigde Staten | 11 |
Rusland | 4 |
Duitsland | 2 |
Sectoraal
Health Technology | 16 |
Consumer Services | 5 |
Finance | 3 |
Health Services | 3 |
Technology Services | 2 |
Operationeel
Director/Board Member | 17 |
Founder | 8 |
Chief Executive Officer | 6 |
Chairman | 3 |
Corporate Officer/Principal | 3 |
Sterkste connecties
Insiders | |
---|---|
Morris Laster | 21 |
Ivan Fedyunin | 10 |
Stacey Pugh | 3 |
Yaron Segal | 1 |
Yotam Drechsler | 1 |
Assaf Lifshitz | 1 |
- Beurs
- Insiders
- Emerita Esther Shohami
- Bedrijfsconnecties